Perjeta (pertuzumab)

$3,445.63

HER2-targeted therapy for breast cancer

SKU: perjeta-pertuzumab Category: Tags: , , ,

Description

Perjeta (pertuzumab) is a monoclonal antibody targeting HER2, used with trastuzumab and chemotherapy for HER2-positive breast cancer.

Reviews

There are no reviews yet.

Be the first to review “Perjeta (pertuzumab)”

Your email address will not be published. Required fields are marked *